BamSEC and AlphaSense Join Forces
Learn More

Traws Pharma Inc.

NASDAQ: TRAW    
Share price (12/24/24): $11.61    
Market cap (12/24/24): $35.1 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.5
from 10-Q 16 pages ​ Traws Pharma, Inc. ​ Employment Agreement
12/34/56
EX-10.4
from DEFA14A 3 pages Title: Flsa Classification: Exempt
12/34/56
EX-10.4
from 8-K 3 pages Title: Flsa Classification: Exempt
12/34/56
EX-10.3
from DEFA14A 17 pages Onconova Therapeutics, Inc. Employment Agreement
12/34/56
EX-10.3
from 8-K 17 pages Onconova Therapeutics, Inc. Employment Agreement
12/34/56
EX-10.2
from DEFA14A 28 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 28 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 40 pages Securities Purchase Agreement
12/34/56
EX-10.1
from DEFA14A 40 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 14 pages Onconova Therapeutics, Inc. ​ Employment Agreement ​
12/34/56
EX-10.1
from 10-Q 14 pages 2021 Incentive Compensation Plan
12/34/56
EX-10.1
from 8-K 3 pages Onconova Therapeutics, Inc. Amendment to Employment Agreement
12/34/56
EX-10.2
from 10-Q 6 pages 1.grant of Option. Subject to the Terms and Conditions Set Forth in This Agreement and in the Plan, the Company Has Granted to the Participant a Nonqualified Stock Option (The “Option”) to Purchase the Number Shares of Common Stock Set Forth on the Stock Option Details Page in Morgan Stanley Stock Plan Connect (“Shares”) at the Exercise Price Per Share Set Forth on the Stock Option Details Page in Morgan Stanley Stock Plan Connect. the Option Shall Become Exercisable According to Section 2 Below. 2. Exercisability of Option
12/34/56
EX-10.1
from 10-Q 4 pages Onconova Therapeutics, Inc. 2021 Incentive Compensation Plan Restricted Stock Unit Agreement
12/34/56
EX-10.2
from 10-Q 14 pages Employment Agreement
12/34/56
EX-10.1
from 10-Q 14 pages ​ Onconova Therapeutics, Inc. ​ Employment Agreement
12/34/56
EX-10.1
from S-8 15 pages Onconova Therapeutics, Inc. 2021 Incentive Compensation Plan
12/34/56
EX-10.15.2
from 10-K 4 pages Onconova Therapeutics, Inc. Amendment to Employment Agreement
12/34/56
EX-10.1
from 8-K 33 pages Purchase Agreement
12/34/56
EX-10.2
from 10-Q 9 pages Onconova Therapeutics, Inc. Stock Appreciation Right Agreement
12/34/56